Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent D922592 Transcutaneous neuromodulation device

Patent D922592 was granted and assigned to Apex Neuro Holdings, Inc. on June, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

Apex Neuro

Current Assignee

‌

Apex Neuro Holdings, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

D922592

Patent Inventor Names

Priyanka Venkatesh0

Zen Chu0

Francois Kress0

Geoff Baldwin0

Jainam Shah0

Sean Hagberg0

Date of Patent

June 15, 2021

Patent Application Number

29693183

Date Filed

May 31, 2019

Patent Citations

‌

US Patent 10695568 Device and method for the treatment of substance use disorders

‌

US Patent 10828461 Transcutaneous electrostimulator and methods for electric stimulation

Patent Citations Received

‌

US Patent D1011535 Portable multimodal multichannel biosignal meter

Patent Primary Examiner

‌

Wan Laymon

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent D922592 Transcutaneous neuromodulation device

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API